Chemistry, biochemistry and clinical pharmacology of digitalis glycosides. An overview
Dwenger, A.
Arzneimittel-Forschung 23(10): 1439-1446
1973
ISSN/ISBN: 0004-4172 PMID: 4273089 Document Number: 60872
Document emailed within 1 workday
Related Documents
Huffman, D.H. 1976: Clinical use of digitalis glycosides American Journal of Hospital Pharmacy 33(2): 179-185Fruton, J.S. 1982: Biochemistry and clinical chemistry--a retrospect Journal of Clinical Chemistry and Clinical Biochemistry 20(4): 243-252
Dybkaer, R. 1979: International Union of Pure and Applied Chemistry and International Federation of Clinical Chemistry. IUPAC Section on Clinical Chemistry Commission on Quantities and Units in Clinical Chemistry and IFCC Committee on Standards Expert Panel on Quantities and Units approved recommendation (1978). List of quantities in clinical chemistry Journal of Clinical Chemistry and Clinical Biochemistry 17(12): 822-835
Terán Dávila, J.é; Teppa Garrán, A.D. 2005: Selective estrogen receptors modulators (SERMs): biochemistry, pharmacology, and clinical use in gynecology Ginecologia y Obstetricia de Mexico 73(8): 424-435
Bresnahan, J.F.; Vlietstra, R.E. 1979: Digitalis glycosides Mayo Clinic Proceedings 54(10): 675-684
Burrus, O. 1987: Digitalis glycosides Revue de l'Infirmiere 37(7): 35-38
Genazzani, E. 1977: Pharmacokinetics of the most commonly used digitalis glycosides Minerva Cardioangiologica 25(11): 861-874
Lehmann, H.U. 1980: Current risks in the use of digitalis glycosides Fortschritte der Medizin 98(5): 172-176
De Micheli, A. 1998: Do digitalis glycosides still serve a purpose? Archivos del Instituto de Cardiologia de Mexico 68(3): 256-261
2002: Abstracts, 2nd International Meeting, The platelet ADP receptors: biochemistry, physiology, pharmacology and clinical aspects. 3-5 October 2002, S. Margherita di Pula, Italy Haematologica 87(10 Suppl. 1): 1-30
Romanov, M.M.; Abbakumov, S.A. 1973: Development of gynecomastia during treatment with digitalis glycosides Sovetskaia Meditsina 36(3): 142-143
De Mey, C.; Snoeck, J. 1980: Review of the use of digitalis glycosides in ventricular dysrhythmia Acta cardiologica 35(2): 153-165
Ecker-Schlipf, B. 2008: Digitalis glycosides. what adverse effects can be avoided? Medizinische Monatsschrift für Pharmazeuten 31(4): 157
Grosse-Brockhoff, F. 1981: Therapy of cardiac insufficiency with digitalis glycosides Fortschritte der Medizin 99(18): 665-668
Singh, B.N.; Cho, Y.W.; Kuemmerle, H.P. 1981: Clinical pharmacology of antiarrhythmic drugs: a review and overview, part Ii International Journal of Clinical Pharmacology Therapy and Toxicology 19(5): 185-199
Sandhage, K. 1971: Treatment of cardiac failure using digitalis glycosides in childhood Zeitschrift für Allgemeinmedizin 47(24): 1220-1226
Patterson, D.F.; Abt, D.A.; Detweiler, D.K.; Knight, D.H.; Buchanan, J.W.; Pyle, R.L. 1973: On digitalis glycosides in treatment of heart failure: criticism and reply Veterinary Medicine-Small Animal Clinician 68(7): 708 Passim
Mikhaĭlov, I.B. 1990: Endogenous digitalis-like substances and cardiac glycosides: facts and hypotheses Farmakologiia i Toksikologiia 53(5): 75-78
Mathis, I.; Parigi, A. 1976: Intentional acute poisoning with digitalis glycosides : therapeutic considerations La Clinica Terapeutica 77(2): 183-192
Lüllmann, H.; Peters, T.; Preuner, J. 1982: Mechanism of action of digitalis glycosides in the light of new experimental observations European Heart Journal 3 Suppl D: 45-51